BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12553733)

  • 1. Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: identification of a distinct transcription start site for the HAI-2 gene in testis.
    Yamauchi M; Itoh H; Naganuma S; Koono M; Hasui Y; Osada Y; Kataoka H
    Biol Chem; 2002 Dec; 383(12):1953-7. PubMed ID: 12553733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hepatocyte growth factor activator inhibitor type 2 (HAI-2)-related small peptide (H2RSP): its nuclear localization and generation of chimeric mRNA transcribed from both HAI-2 and H2RSP genes.
    Itoh H; Kataoka H; Yamauchi M; Naganuma S; Akiyama Y; Nuki Y; Shimomura T; Miyazawa K; Kitamura N; Koono M
    Biochem Biophys Res Commun; 2001 Oct; 288(2):390-9. PubMed ID: 11606055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human.
    Itoh H; Kataoka H; Hamasuna R; Kitamura N; Koono M
    Biochem Biophys Res Commun; 1999 Feb; 255(3):740-8. PubMed ID: 10049781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator.
    Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
    Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
    Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues.
    Yamada T; Tsujioka Y; Taguchi J; Takahashi M; Tsuboi Y; Shimomura T
    Exp Neurol; 1998 Sep; 153(1):60-4. PubMed ID: 9743567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma levels of hepatocyte growth factor and its associated factors during pregnancy.
    Watanabe T; Sakata Y; Matsubara S; Yamagishi T; Nagaike K; Kuwata T; Suzuki M
    J Obstet Gynaecol Res; 2006 Feb; 32(1):10-4. PubMed ID: 16445520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa.
    Itoh H; Kataoka H; Tomita M; Hamasuna R; Nawa Y; Kitamura N; Koono M
    Am J Physiol Gastrointest Liver Physiol; 2000 Apr; 278(4):G635-43. PubMed ID: 10762618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.
    Kirchhofer D; Peek M; Lipari MT; Billeci K; Fan B; Moran P
    FEBS Lett; 2005 Mar; 579(9):1945-50. PubMed ID: 15792801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo.
    Miyata S; Uchinokura S; Fukushima T; Hamasuna R; Itoh H; Akiyama Y; Nakano S; Wakisaka S; Kataoka H
    Cancer Lett; 2005 Sep; 227(1):83-93. PubMed ID: 16051034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HAI-1 expression in villous tissue of early gestational period in women].
    Fan CB; He JL; Wang YX; Liu XQ; Chen XM; Li HM; Ding YB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):602-5. PubMed ID: 16909612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta.
    Tanaka H; Nagaike K; Takeda N; Itoh H; Kohama K; Fukushima T; Miyata S; Uchiyama S; Uchinokura S; Shimomura T; Miyazawa K; Kitamura N; Yamada G; Kataoka H
    Mol Cell Biol; 2005 Jul; 25(13):5687-98. PubMed ID: 15964823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis.
    Kaido T; Oe H; Yoshikawa A; Okajima A; Imamura M
    Hepatogastroenterology; 2004; 51(56):547-51. PubMed ID: 15086199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor.
    Kawaguchi T; Qin L; Shimomura T; Kondo J; Matsumoto K; Denda K; Kitamura N
    J Biol Chem; 1997 Oct; 272(44):27558-64. PubMed ID: 9346890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta.
    Kataoka H; Meng JY; Itoh H; Hamasuna R; Shimomura T; Suganuma T; Koono M
    Histochem Cell Biol; 2000 Dec; 114(6):469-75. PubMed ID: 11201608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells.
    Akiyama Y; Nagai M; Komaki W; Marutsuka K; Asada Y; Kataoka H
    Hum Cell; 2006 Aug; 19(3):91-7. PubMed ID: 17204092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth.
    Fan B; Brennan J; Grant D; Peale F; Rangell L; Kirchhofer D
    Dev Biol; 2007 Mar; 303(1):222-30. PubMed ID: 17174946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of GST-HAI-1 fusion protein and development of monoclonal antibody against human hepatocyte growth factor activator inhibitor 1].
    Chen HX; Cao J; Shen JG; Zheng S
    Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):496-500. PubMed ID: 15968977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepatocyte growth factor activator inhibitor type I (HAI-I) and type 2 (HAI-2) in prostate cancer.
    Nagakawa O; Yamagishi T; Akashi T; Nagaike K; Fuse H
    Prostate; 2006 Apr; 66(5):447-52. PubMed ID: 16353247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma.
    Yamauchi M; Kataoka H; Itoh H; Seguchi T; Hasui Y; Osada Y
    J Urol; 2004 Feb; 171(2 Pt 1):890-6. PubMed ID: 14713848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.